Serial biopharma founder seeks to transform an Alzheimer’s drug into an autism therapy

For years, hundreds of thousands of Alzheimer’s or dementia patients like local entrepreneur Mark Tepper’s late mother have relied on a drug with a modest benefit. Tepper thinks his new company can broaden its impact.